BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study

Triple-negative breast cancer (TNBC) has several subtypes. The identification of markers associated with recurrence and poor prognosis in patients with TNBC is urgently needed. BRCAness is a set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation, or deletion, results in DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosaka, Yoshimasa, Yamamoto, Yutaka, Tanino, Hirokazu, Nishimiya, Hiroshi, Yamamoto-Ibusuki, Mutsuko, Hirota, Yuko, Iwase, Hirotaka, Nakamura, Seigo, Akashi-Tanaka, Sadako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168149/
https://www.ncbi.nlm.nih.gov/pubmed/32098267
http://dx.doi.org/10.3390/diagnostics10020119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168149/
https://www.ncbi.nlm.nih.gov/pubmed/32098267
http://dx.doi.org/10.3390/diagnostics10020119

Ejemplares similares